Pernod Ricard’s Sales Fell 3.9% — The Next Turnaround Lever May Be the Balance Sheet
Cost cuts defended margins and cash flow improved, but weak U.S. and China demand left leverage elevated — putting capital allocation at the centre of the next phase of the turnaround.

Pernod Ricard’s full-year results show a company improving cash discipline while its two most important weak spots — the U.S. and China — continue to drag on sales.
Organic revenue fell 3.9% in fiscal 2026, the third consecutive annual decline reported by Reuters. Management defended operating margin through cost cuts and lifted free cash flow 6%, but leverage still rose to 3.7 times EBITDA because profit fell faster than debt.
What happened
Net sales were €9.404 billion. Organic profit from recurring operations declined 5.2% to €2.423 billion.
The U.S. fell 14% organically and the broader Americas region dropped 10%. China remained weak. Pernod says conditions improved in the second half, with the organic sales decline narrowing from 5.9% in H1 to 1.3% in H2.
The company has accelerated a €1 billion efficiency programme and expects full delivery by FY28.
What everyone is looking at
The market naturally wants the U.S. and China to stabilise.
But the balance sheet determines how long Pernod can wait for that recovery without sacrificing strategic flexibility. Net debt was €10.662 billion and net debt/EBITDA increased to 3.7x.
What the market may be missing
Cash flow and leverage are moving in opposite directions for a reason.
Free cash flow improved 6% to €1.197 billion and cash conversion rose sharply to 91%. Those are genuine positives. Yet weaker operating profit keeps leverage elevated even as absolute debt fell slightly.
That puts capital allocation in focus. Pernod is proposing a stable €4.70 dividend and offering shareholders a share-payment option for the final dividend. Investors will increasingly ask how management balances distributions, deleveraging and brand investment while growth is soft.
The numbers
- Organic sales: -3.9% - Net sales: €9.404B - Organic recurring operating profit: -5.2% - Free cash flow: €1.197B, +6% - Net debt: €10.662B - Net debt/EBITDA: 3.7x - Proposed dividend: €4.70/share
Positive case
U.S. inventory adjustment ends, China improves and efficiency savings flow through while free cash flow remains strong. Leverage then falls quickly without sacrificing marketing investment.
Downside case
Alcohol demand stays structurally weak in the U.S., China remains soft and pricing power fades. Cost cuts may protect margin temporarily, but insufficient top-line growth makes debt reduction slower.
What would change the story
Watch U.S. sell-out trends, China demand, FY27 organic guidance, net debt, cash conversion and any change to dividend or buyback policy.
Related themes
Pernod Ricard, Diageo, premium spirits, consumer demand, China, U.S. discretionary spending and European corporate leverage.
PriceVia view
The turnaround is no longer just about selling more bottles. Pernod has to show that cash discipline can repair leverage before weak demand forces a harder capital-allocation choice.
Sources & timestamp
Pernod Ricard official FY26 results dated August 27, 2026 and Reuters-syndicated Euronext coverage; verified August 28 morning IST.
Market-risk disclaimer
For information only; not investment advice.